Alpha-Rich Ideas
ExOne: A $15 Stock On Sale For $46
by Brian Smith, Jr.
Editor's notes: Limits to XONE's sales and business model don't mesh well with a sky-high valuation. Smith says the stock should be valued 67% lower even if the company meets its targets.
Brazil Fast Food Has A Margin Of Safety With Significant Upside
by Nick Ghattas
Editor's notes: The fast food company is on the verge of increasing profits, debt paydown, and capital returns, making it a nice under the equator play. Ghattas forecasts triple-digit upside.
Editors' Picks
Starbucks: Kraft Lawsuit Provides A Rare Investment Opportunity by Moses Li
Expectations Rising For ABM Industries by Gary Bourgeault
Recent Run At Guess? Creates Compelling Short Opportunity by Vince Martin
Microsemi Offers Underrated Potential by Stephen Simpson
Salesforce.com: The Charade Continues With Recent Acquisition by Tim Travis
HCI Group: Inadequate Reinsurance Coverage Poses Potentially Catastrophic Risks To Shareholders, Policyholders And Taxpayers by Xuhua Zhou
Acadia Has A Silver Lining In Its Playbook by PTSD Trader
Buy These 3 Biotechs To Corner The Parkinson's Disease Market by Jason Napodano
As The Patent Cliff Approaches, Buy TrovaGene by Logical Assessment
Tesla Isn't The Only Company Riding Auto Evolution by Redrut
Long Ideas
Titan Machinery: Company Set To Capitalize On Long-Term Food Production Demand by Money Investor
Starbucks: Kraft Lawsuit Provides A Rare Investment Opportunity by Moses Li
Expectations Rising For ABM Industries by Gary Bourgeault
Starbucks: Can The Growth Continue? by Catalyst Investments
Asset Play: Frisch Restaurants by Bram de Haas
Polaris Industries - On An Enviable Growth Trajectory by Salman Ebrahim
Cimarex: Is Deutsche Bank's $99 Target Realistic? by Michael Fitzsimmons
CSP Is A Tech Stock You Should Be Adding To Your Portfolio by Elisa Lemmola
Longleaf Partners Reveal Where Ex-Chesapeake CEO McClendon Lost Their Support by Devon Shire
Target: Stay Cautious by Stock Gamer
RBC's Analysis Of Nokia Is Questionnable by Charles Santerre
Shorting BlackBerry: What You Need To Know by Infinity Group
Intel Works To Develop Monolithic Integration Of Wifi And RF, Part I by Mordechai Rorvig
A Threat To Big Soda? by Bill Gunderson
Apple Should Drive Higher Going Into Monday's Developer Conference by Adam Betancourt
AT&T - Upside Potential Of 20% by The Ethical Investor
SUPERVALU Vs. Roundy's: Case Study Comparing 2 Struggling Grocery Retailers by Saibus Research
Why Google Chrome Will Crack Windows by Capital Recharge
Ambarella: After Shares Have Nearly Tripled, Upside Potential Remains by The Value Investor
Must Buy Auto Stocks For 2013 by Fusion Research
RAVN: A Unique Opportunity To Purchase A Premier Industrial Asset by 20 Slots
Ambarella: Growth At A Reasonable Price by ONeil Trader
Hexcel Corporation: A Buy On Business Strategy by Fundamental Analyst
Silex Systems: The Future Of The Uranium Enrichment Industry by Teenie Cap Research
Ambarella Exhibits Greater Growth Potential Compared To Semiconductor Industry by Market Analytics
Hanger Inc.: Sustainable Competitive Advantages by Nikhil Raheja
AbbVie Pharmaceuticals - High Risk With Little Upside Potential by Market Analytics
IBM: Bet On Big Blue's Boom? by Marshall Hargrave
Dell: Can It Prosper By Turning The Virtual Desktop Into Gold? by Adetokunbo Abiola
Universal Health Services Is Buy For A Long-Term Horizon by Investment Analytics
Johnson & Johnson: When Special Items Are The Norm by Robert Honeywill
Key Take Aways From The Tesla Motors Annual Shareholder Meeting by Wall Street Elevator
Ascena Retail: Expected To Beat Market Consensus Estimates; A Long-Term Buy by Alpha Hunter
Citigroup: Positioned For Growth But Pressures Still Exist by Dave Dierking
Middleby Corporation Is Decent Bet For Growth Investors by Alpha Hunter
These 3 Drug Stocks May Cure Summertime Blues by Todd Campbell
Qualcomm's Growth Is On Sale by Stock Gamer
Microsemi Offers Underrated Potential by Stephen Simpson
Medtronic: CoreValve's Long Road To U.S. Approval by Peter Geschek
5 Reasons I Wouldn't Want To Be Shorting Vringo Right Now by Justin Giles
Intel: The Big Jigsaw Puzzle by Russ Fischer
Foot Locker: Daddy Needs A New Pair Of Shoes by Adam Betancourt
Nokia: Things Are Looking Up by Jacob Steinberg
Could Money Grow On Vertically Farmed Plants? by Bohsie
Microsoft And Nokia: Windows Phone Advertising Working by Abu Bakr Hussain
Sonus And AudioCodes: Your 1-2 Punch For Potential Takeovers by Josh Franklin
Comstock Resources: Fundamentals Finally Turn Bullish by Michael Fitzsimmons
What Iluvien May Mean To Alimera And PSivida by Smith On Stocks
Competitive Advantages, Huge Skin Cancer Market Bode Well For Aura by Brian Marckx
Inter Parfums Is An Attractive Small-Cap Pick by IAEResearch
Acadia Has A Silver Lining In Its Playbook by PTSD Trader
Rosetta Resources: Eagle Ford Play Is Gaining Momentum by Bret Jensen
Evaluating Cloud Computing And The Salesforce.com Acquisition by Bottom Up Investing
Colgate's Essential Products Lead To Dependable Growth by Delian Naydenov
As Delta Sheds Its Memphis Hub, Expansion Efforts In Major Cities Could Become Common by Heather Ingrassia
Cloud Consolidation Accelerates And Gets Expensive by Dana Blankenhorn
Tesla Short Squeeze, We've Seen This Before by Nick Gagnon
VIX Is Alive And Kicking by Nico Inberg
Laclede Rate Case Agreement Filed by Finjitsu Research
Wal-Mart: Still Offering Great Value by David Trainer
Cyber Security The Next Big Thing In Internet Stocks; Lessons From The Tech Bubble by Alberto Savrieno
pSivida Drug Technology And Pipeline Make It One Of The Most Undervalued Biotechs For 2013 by Bob's Stocks
Wet Seal Could Become The Turnaround Story Of 2013 In The Retail Sector by Unbigoted Research
As The Patent Cliff Approaches, Buy TrovaGene by Logical Assessment
A Good Value In The Biotech Sector? by Bill Gunderson
Tesla Isn't The Only Company Riding Auto Evolution by Redrut
Fuel-Tech Is Undervalued And Offers Intriguing Value To Shareholders by Daniel Philip
Short Ideas
Omega Protein: Why EBITDA Is Set To Be Cut In Half by LongShort 101
Recent Run At Guess? Creates Compelling Short Opportunity by Vince Martin
Objet Founders Sue Stratasys Directors For Commercial Misconduct by NewAngle Research
Homebuilder Fundamentals: 2 (More) Classic Examples Of Shareholder Dilution by Brian Gilmartin
Salesforce.com: The Charade Continues With Recent Acquisition by Tim Travis
HCI Group: Inadequate Reinsurance Coverage Poses Potentially Catastrophic Risks To Shareholders, Policyholders And Taxpayers by Xuhua Zhou
Disagreeing On Marvell's Prospects by Paulo Santos
Stamps.com - A Short Story by Madhusudan Rao
Molycorp: A Dark Road Ahead by StockPro2X
Tesla Conference Notes: Musk Says 'We Don't Want To Suck' by Philip Davis
Quick Picks & Lists
2 Small Cap Picks For Right Now by Cecil Sales
Don't Miss These Rebounding Banks In 2013 by Fusion Research
Will Brunswick Corporation Grow As Expected? by Jarrod W. Jacinth
4 Good Investment Selections Regardless Of Market Trend by Brian Nichols
Possible Devaluation Of The Euro Casts A Shadow Over Gold's Future by Bob Kirtley
Salesforce Fills Out The 'Marketing Cloud' by Michael Fauscette
Zynga Slashes Headcount As It Struggles To Transform Its Business by Trefis
Bull Of The Day: Restoration Hardware by Zacks Investment Research
I Am Not Convinced E-Commerce Will Work For Amazon by John Mylant
AxoGen Sets Stage For Growth In Canada by Cockrell Group
Options In Play On Fairway Ahead Of Earnings by Interactive Brokers
When To Sell High-Flying Stocks by BubbleBustInvesting
Opportunities Remain To Find Bargains by David Brown
Why You Shouldn't Miss These Tech Stocks In 2013 by Futuristics
BDC Risk Profiles: Part 11 - Credit Quality by BDC Buzz
Mobile Device Wars Move Beyond Tech Strategy by Richard Cox
What Must Be In The Ideal Biopharmaceutical Portfolio? by Emerging Equities
Buy These 3 Biotechs To Corner The Parkinson's Disease Market by Jason Napodano
Lululemon Poised To Pop After Ironing Out Pants Issue by Renee Butler
2 Undervalued Ideas For This Bull Market by Value Trap Blog
Cramer's Picks
Cramer's Lightning Round - Higher Rates Are Good For First Interstate (6/5/13) by SA Editor Miriam Metzinger
Cramer's Mad Money - Pandora Shouldn't Go Against A Wounded Apple (6/5/13) by SA Editor Miriam Metzinger
Fund Holdings
SolarCity And Other Top Solar Picks By Legendary Fund Managers by GuruFundPicks
Notes On The Las Vegas Value Investing Congress by Value Investing Congress
Monday's Top Biotech Losers Infinity And Synta And Other Top Sells By Fund Managers by GuruFundPicks
IPO Analysis
IPO Preview: LightInTheBox Holding by IPOdesktop
Why are you receiving this? You subscribed to Investing Ideas at Seeking Alpha.
Unsubscribe from this email or manage all your Seeking Alpha email choices here.
To ensure you receive these emails in the future, please add account@seekingalpha.com to your address book, contacts or list of safe senders.
Sent by Seeking Alpha, 345 7th Ave. Suite 1400 New York, NY 10001
No hay comentarios:
Publicar un comentario